Rhenman & Partners Asset Management AB Has $10.57 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Rhenman & Partners Asset Management AB reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 49.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,000 shares of the medical device company’s stock after selling 113,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Cooper Companies were worth $10,572,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Byrne Asset Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth approximately $33,000. OFI Invest Asset Management bought a new position in Cooper Companies in the fourth quarter worth $34,000. New Age Alpha Advisors LLC acquired a new stake in Cooper Companies during the fourth quarter worth $38,000. West Financial Advisors LLC bought a new stake in Cooper Companies in the 4th quarter valued at $49,000. Finally, Atala Financial Inc acquired a new position in shares of Cooper Companies in the 4th quarter valued at $51,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

Shares of COO stock opened at $73.77 on Friday. The Cooper Companies, Inc. has a 52 week low of $73.34 and a 52 week high of $112.38. The stock has a market capitalization of $14.75 billion, a PE ratio of 37.83, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock’s fifty day moving average is $87.76 and its 200-day moving average is $96.33.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several recent research reports. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Wells Fargo & Company increased their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.